Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care
NCT ID: NCT01033162
Last Updated: 2019-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
368 participants
INTERVENTIONAL
2009-11-30
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will be conducted within the Kaiser Permanente Northwest (KPNW) healthcare system. Outcomes for this study include amount of ICCS use and women's ratings of cancer information competence, perceived social support, and emotional well being. Secondary outcomes will include healthcare utilization, cost-effectiveness, and clinician ratings of healthcare visits.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Component and Couple Analysis of Cancer Communications
NCT00468741
Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers
NCT00365963
CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer
NCT00214162
Interactive Cancer Communication System (ICCS) Directed Physical Activity Enhancement for Colon Cancer Survivors
NCT01133132
CHESS: Human and Computer Mentors for Prostate Cancer Patients
NCT00516256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
A group using a Basic ICCS provided by KPNW
No interventions assigned to this group
Intervention
A group using an enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)
Enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)
Half of the participating women will be randomly assigned to use an informative but static website (Basic ICCS), and half will be offered a fully interactive CHESS (Enhanced ICCS + the Basic ICCS). Study outcome data will be gathered from patients, clinicians, and the healthcare system (i.e., from the electronic medical record: EMR) for at least 8 months after study entry. We propose that the Enhanced ICCS relative to the Basic ICCS, will:
* Improve patients' sense of cancer information competence (perceived ability to obtain and use relevant information)
* Reduce patients' negative affect and increase their emotional well being
* Improve patients' sense of social support
* Improve patients' health self-efficacy
* Improve patients' ratings of experience with cancer specialty care services
* Improve patients' health related quality of life (HRQL)
* Improve clinicians' ratings of quality of patient contacts
* Reduce healthcare utilization and costs (obtained via the EMR)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)
Half of the participating women will be randomly assigned to use an informative but static website (Basic ICCS), and half will be offered a fully interactive CHESS (Enhanced ICCS + the Basic ICCS). Study outcome data will be gathered from patients, clinicians, and the healthcare system (i.e., from the electronic medical record: EMR) for at least 8 months after study entry. We propose that the Enhanced ICCS relative to the Basic ICCS, will:
* Improve patients' sense of cancer information competence (perceived ability to obtain and use relevant information)
* Reduce patients' negative affect and increase their emotional well being
* Improve patients' sense of social support
* Improve patients' health self-efficacy
* Improve patients' ratings of experience with cancer specialty care services
* Improve patients' health related quality of life (HRQL)
* Improve clinicians' ratings of quality of patient contacts
* Reduce healthcare utilization and costs (obtained via the EMR)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All subjects must be at least 18 years of age
Exclusion Criteria
* Homeless
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy Baker
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Northwest
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Wisconsin Carbone Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XP08323
Identifier Type: OTHER
Identifier Source: secondary_id
NCI-2013-01101
Identifier Type: REGISTRY
Identifier Source: secondary_id
A534253
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH/MEDICINE/MEDICINE*G
Identifier Type: OTHER
Identifier Source: secondary_id
H-2008-0222
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.